Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells

Blood

Volumn 98, Issue 13, 2001, Pages 3717-3726

  Longo, Natividad ^a   Yáñez Mó, María ^a   Mittelbrunn, María ^a   De La Rosa, Gonzalo ^a   Muñoz, María Luisa ^a   Sánchez Madrid, Francisco ^a   Sánchez Mateos, Paloma ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD9 ANTIGEN; TETRASPANIN;

ARTICLE; CANCER INVASION; CELL INTERACTION; CELL MIGRATION; COMPLEX FORMATION; CONFOCAL MICROSCOPY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; TUMOR GROWTH;

EID: 0035895069     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.13.3717     Document Type: Article

References (46)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70.
2. Fidler I. Molecular biology of cancer: invasion and metastasis. In: Vincent T, DeVita SH, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 5th ed. Philadelphia, PA: Lippincott-Raven; 1997.
3. Quigley JP, Armstrong PB. Tumor cell intravasation alu-cidated: the chick embryo opens the window. Cell. 1998;94:281-284.
4. Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol, 1999;155:739-752.
5. Chang YS, di Tomaso E, McDonald DM, Jones R, Jain RK, Munn LL. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A. 2000;97:14608-14613.
6. Yáñez-Mó M, Tejedor R, Rousselle P, Sanchez-Madrid F. Tetraspanins in intercellular adhesion of polarized epithelial cells: spatial and functional relationship to integrins and cadherins. J Cell Sci. 2001;114:577-587.
7. Maecker HT, Todd SC, Levy S. The tetraspanin superfamily: molecular facilitators. FASEB J. 1997;11:428-442.
8. Hemler ME. Integrin associated proteins. Curr Opin Cell Biol. 1998;10:578-585.
9. Boucheix C, Thien Duc GH, Jasmin C, Rubinstein E. Tetraspanins and malignancy. Exp Rev Mol Med. 2001:1-17.
10. Kondoh M, Ueda M, Ichihashi M, Mishima Y. Decreased expression of human melanoma-associated antigen ME491 along the progression of melanoma pre-canceroses to invasive and metastatic melanomas. Melanoma Res. 1993;3:241-245.
11. Miyake M, Nakano K, Itoi SI, Koh T, Taki T. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res. 1996;56:1244-1249.
12. Cajot JF, Sordat I, Silvestre T, Sordat B. Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res. 1997;57:2593-2597.
13. Guo XZ, Friess H, Di Mola FF, et al. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma. Hepatology. 1998;28:1481-1488.
14. Testa JE, Brooks PC, Lin JM, Quigley JP. Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res. 1999;59:3812-3820.
15. Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med. 1993;177:1231-1237.
16. Radford KJ, Mallesch J, Hersey P. Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int J Cancer. 1995;62:631-635.
17. Dong JT, Lamb PW, Rinker-Schaeffer CW, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11 p11.2. Science. 1995;268:884-886.
18. Tang DG, Honn KV. Adhesion molecules and tumor metastasis: an update. Invasion Metastasis. 1994;14:109-122.
19. Orr FW, Wang HH, Lafrenie RM, Scherbarth S, Nance DM. Interactions between cancer cells and the endothelium in metastasis. J Pathol. 2000;190:310-329.
20. Chen YQ, Duniec ZM, Liu B, et al. Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Cancer Res. 1994;54:1574-1579.
21. Honn KV, Tang DG, Grossi I, et al. Tumor cellderived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. Cancer Res. 1994;54:565-574.
22. Kusama T, Nakamori S, Ohigashi H, et al. Enhancement of in vitro tumor-cell transcellular migration by tumor-cell-secreted endothelial-cell-retraction factor. Int J Cancer. 1995;63:112-118.
23. Ito A, Katoh F, Kataoka TR, et al. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J Clin Invest. 2000;105:1189-1197.
24. Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med. 1999;5:221-225.
25. Jaffe E, Nachman RL, Becker CG, Minick RC. Culture of human endothelial cells derived from umbilical veins. Circulation. 1972;46:211-253.
26. Kozlowski JM, Fidler IJ, Campbell D, Xu ZL, Kaighn ME, Hart IR. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res. 1984;44:3522-3529.
27. Hemler ME, Sanchez-Madrid F, Flotte TJ, et al. Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol. 1984;132:3011-3018.
28. Peñas PF, García-Diez A, Sánchez-Madrid F, Yañez-Mó M. Tetraspanins are localized at motility-related structures and involved in normal human keratinocyte wound healing migration. J Invest Dermatol. 2000;114:1126-1135.
29. Barnstable CJ, Bodmer WF, Brown G, et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell. 1978;14:9-20.
30. Yañez-Mó M, Alfranca A, Cabanas C, et al. Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions. J Cell Biol. 1998;141:791-804.
31. Leach L, Clark P, Lampugnani MG, Arroyo AG, Dejana E, Firth JA. Immunoelectron characterization of the inter-endothelial junctions of human term placenta. J Cell Sci. 1993;104:1073-1081.
32. Parham P, Androlewicz MJ, Brodsky FM, Holmes NJ, Ways JP. Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens. J Immunol Methods. 1982;53:133-173.
33. Sanchez-Mateos P, Campanero MR, Balboa MA, Sanchez-Madrid F. Co-clustering of beta 1 integrins, cytoskeletal proteins, and tyrosinephosphorylated substrates during integrin-mediated leukocyte aggregation. J Immunol. 1993;151:3817-3828.
34. Lewalle JM, Bajou K, Desreux J, et al. Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro. Exp Cell Res. 1997;237:347-356.
35. Pawlowski NA, Kaplan G, Abraham E, Cohn ZA. The selective binding and transmigration of monocytes through the junctional complexes of human endothelium. J Exp Med. 1988;168:1865-1882.
36. Muller WA, Ratti CM, McDonnell SL, Cohn ZA. A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med. 1989;170:399-414.
37. Kramer RH, Nicolson GL. Interactions of tumor cells with vascular endothelial cell monolayers: a model for metastatic invasion. Proc Natl Acad Sci U S A. 1979;76:5704-5708.
38. Lafrenie R, Shaughnessy SG, Orr FW, Cancer cell interactions with injured or activated endothelium, Cancer Metastasis Rev. 1992;11:377-388.
39. Chambers AF, MacDonald IC, Schmidt EE, et al. Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer Metastasis Rev. 1995;14:279-301.
40. Sandig M, Voura EB, Kalnins VI, Siu CH. Role of cadherins in the transendothelial migration of melanoma cells in culture. Cell Motil Cytoskeleton. 1997;38:351-364.
41. Allport JR, Muller WA, Luscinskas FW. Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow. J Cell Biol. 2000;148:203-216.
42. Masellis-Smith A, Jensen GS, Seehafer JG, Slupsky JR, Shaw AR. Anti-CD9 monoclonal antibodies induce homotypic adhesion of pre-B cell lines by a novel mechanism. J Immunol. 1990;144:1607-1613.
43. Letarte M, Seehafer JG, Greaves A, Masellis-Smith A, Shaw AR. Homotypic aggregation of pre-B leukemic cell lines by antibodies to VLA integrins correlates with their expression of CD9. Leukemia. 1993;7:93-103.
44. Matsumoto AK, Martin DR, Carter RH, Klickstein LB, Ahearn JM, Fearon DT. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J Exp Med. 1993;178:1407-1417.
45. Fitter S, Sincock PM, Jolliffe CN, Ashman LK. Transmembrane 4 superfamily protein CD151 (PETA-3) associates with beta 1 and alpha lib beta 3 integrins in haemopoietic cell lines and modulates cell-cell adhesion. Biochem J. 1999;338:61-70.
46. Yáñez-Mó M, Mittelbrunn M, Sánchez-Madrid F. Tetraspanins and intercellular interactions. Microcirculation. 2001;8:153-168.